Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C FitzGerald

Showing results (261-270 of 1,358) with videos related to

Pageof 136
Sort By:
Gastroenterology|March 27, 2018
New Screening Techniques in Barrett's Esophagus: Great Ideas or Great Practice?Stuart J Spechler, David A Katzka, Rebecca C Fitzgerald
ANZ Journal of Surgery|September 21, 2022
Interpretation of computed tomography of the cervical spine by non-radiologists: a systematic review and meta-analysisSuhail Wani, Mark C Fitzgerald, Dinesh Varma, et al.
Topics in Hospital Pharmacy Management|January 9, 1990
Professional autonomy in the practice of pharmacyW T Sawyer, P A Seward, K C Fitzgerald
Biochimica Et Biophysica Acta|February 28, 1983
Kinetic studies of the demetallization and inactivation of concanavalin AP C FitzGerald, R D Farina, W D Behnke
Biophysical Journal|September 1, 1994
Effect of acid predissolution on fibril size and fibril flexibility of synthetic beta-amyloid peptideC L Shen, M C Fitzgerald, R M Murphy
Metabolism: Clinical and Experimental|September 1, 1989
Fibrinolytic capacity following stimulation with desmopressin acetate in patients with diabetes mellitusM B Grant, C Fitzgerald, C Guay, et al.
Annual Review of Biomedical Engineering|May 21, 2013
eHealth: extending, enhancing, and evolving health careCarlos A Meier, Maria C Fitzgerald, Joseph M Smith
Analytical Chemistry|November 8, 2018
Chemo-Selection Strategy for Limited Proteolysis Experiments on the Proteomic ScaleRenze Ma, He Meng, Nancy Wiebelhaus, et al.
Quaderni Sclavo Di Diagnostica Clinica E Di Laboratorio|March 1, 1973
Proceedings: SGOT and CPK isoenzymes in clinical medicineG Anido, J C Fitzgerald, A Soto, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 9, 2023
Extended interval dosing of ocrelizumab in patients with multiple sclerosis is not associated with meaningful differences in disease activityNicole Bou Rjeily, Kathryn C Fitzgerald, Ellen M Mowry
Pageof 136

Showing results (261-270 of 1,358) with videos related to

Sort By:
Pageof 136
Gastroenterology|March 27, 2018
New Screening Techniques in Barrett's Esophagus: Great Ideas or Great Practice?Stuart J Spechler, David A Katzka, Rebecca C Fitzgerald
ANZ Journal of Surgery|September 21, 2022
Interpretation of computed tomography of the cervical spine by non-radiologists: a systematic review and meta-analysisSuhail Wani, Mark C Fitzgerald, Dinesh Varma, et al.
Topics in Hospital Pharmacy Management|January 9, 1990
Professional autonomy in the practice of pharmacyW T Sawyer, P A Seward, K C Fitzgerald
Biochimica Et Biophysica Acta|February 28, 1983
Kinetic studies of the demetallization and inactivation of concanavalin AP C FitzGerald, R D Farina, W D Behnke
Biophysical Journal|September 1, 1994
Effect of acid predissolution on fibril size and fibril flexibility of synthetic beta-amyloid peptideC L Shen, M C Fitzgerald, R M Murphy
Metabolism: Clinical and Experimental|September 1, 1989
Fibrinolytic capacity following stimulation with desmopressin acetate in patients with diabetes mellitusM B Grant, C Fitzgerald, C Guay, et al.
Annual Review of Biomedical Engineering|May 21, 2013
eHealth: extending, enhancing, and evolving health careCarlos A Meier, Maria C Fitzgerald, Joseph M Smith
Analytical Chemistry|November 8, 2018
Chemo-Selection Strategy for Limited Proteolysis Experiments on the Proteomic ScaleRenze Ma, He Meng, Nancy Wiebelhaus, et al.
Quaderni Sclavo Di Diagnostica Clinica E Di Laboratorio|March 1, 1973
Proceedings: SGOT and CPK isoenzymes in clinical medicineG Anido, J C Fitzgerald, A Soto, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 9, 2023
Extended interval dosing of ocrelizumab in patients with multiple sclerosis is not associated with meaningful differences in disease activityNicole Bou Rjeily, Kathryn C Fitzgerald, Ellen M Mowry
Pageof 136